Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CRAFT Magister is an Indica-dominant medical cannabis flower product developed and distributed by DEMECAN. It is derived from the 'Black Marker' cultivar, which is a genetic cross of (Biscotti x Sherb BX) x Jealousy. CRAFT Magister is cultivated in Canada by Big League and imported un-irradiated into Germany. It is characterized by a high tetrahydrocannabinol (THC) content (ranging from approximately 24% to 31%) and a low cannabidiol (CBD) content (around 1%). The terpene profile is dominated by beta-caryophyllene, limonene, linalool, and nerolidol, giving it a creamy, diesel-like, and citrusy aroma. CRAFT Magister is prescribed for the treatment of chronic pain, sleep disorders (insomnia), depression, appetite loss, and stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CRAFT Magister.